Switch to:
GuruFocus articles
Headlines from internet
Nov-21-17$144.83 (+2.45%)
11:03AMBiotech Forum Daily Digest Now Sarepta Seekingalpha
Nov-20-17$141.37 (-4.07%)
12:39PMSix promising stocks to buy when the biotech correction ends MarketWatch
08:27AMRoche Obtains Fda Approval Hemophilia Drug Time Push Shire Seekingalpha
04:07AMRoche Stock Surges on Trial Successes in Cancer, Haemophilia theStreet
Nov-18-17
09:02AMWhy your doctor may soon have you playing video games MarketWatch
Nov-17-17$147.37 (+1.89%)
04:16PMUltragenyx's rhGUS Gets FDA Nod for Rare Genetic Disease Zacks
08:05AMRoche's (RHHBY) Hemophilia A Drug Receives FDA Approval Zacks
Nov-16-17$144.63 (+3.29%)
09:42PMSangamos Powerful Pipeline Drives Significant Upside Seekingalpha
Nov-14-17$139.27 (+0.69%)
09:09AMShire Gets Positive CHMP Opinion for Hemophilia A Drug Zacks
Nov-08-17$141.31 (-2.34%)
12:01PMSarepta Therapeutics Will Continue Ride High Exondys 51s Success 2017 Seekingalpha
Nov-07-17$144.69 (-1.67%)
06:02AMThe Only 3 Big Pharma Companies Growing Market Share Fool
Nov-01-17$145.75 (-1.27%)
04:07PMBiotechs Behaving Badly Analysis Seekingalpha
10:48AMAllergan (AGN) Tops Q3 Earnings Estimates, Tweaks 2017 View Zacks
Oct-31-17$147.63 (+1.28%)
11:11AMShire Q3 2017 Ready Fly Seekingalpha
Oct-30-17$145.76 (+2.53%)
03:03PMRadius Health Trading Near Lows Several Catalysts Coming Seekingalpha
10:53AMShire (SHPG) Q3 Earnings Beat, Immunology Franchise Strong Zacks
Oct-27-17$142.17 (+2.84%)
03:06PMShire Plc 2017 Q3 Results Earnings Call Slides Seekingalpha
Oct-26-17$138.24 (-3.79%)
11:16AMAllergan (AGN) to Report Q3 Earnings: What's in the Cards? Zacks
Oct-24-17$144.5 (-0.19%)
12:01AMNeuroscientists could soon have you playing video games MarketWatch
Oct-18-17$146.29 (-3.79%)
06:15PMGeneric Restasis Risk Metastasizes Shire Seekingalpha
Oct-17-17$152.05 (-2.08%)
04:44PMAllergan (AGN) Loses Restasis Patent Lawsuit, Shares Fall Zacks
Oct-16-17$155.28 (+0.79%)
09:02AMShire's New Formulation of Oncaspar Gets CHMP Recommendation Zacks
Oct-12-17$152.28 (+0.18%)
01:38PMShire Q3 2017 Earnings Preview Seekingalpha
Oct-06-17$151.09 (-1.47%)
03:10PMSenator Seeks Thwart Allergans Patent Transfer Seekingalpha
Oct-05-17$153.34 (-0.63%)
05:52PMInterview Shire Controversial Dry Eye Market Seekingalpha
Oct-04-17$154.31 (+0.44%)
01:12PMShire Sues Allergan Dry Eye Donnybrook Seekingalpha
Sep-30-17
08:00AM3 Things Biotech Learn Today September 30 2017 Seekingalpha
Sep-29-17
09:45AMKeep Patience Shire Seekingalpha
Sep-26-17$150.7 (-2.54%)
06:18AMNektar Therapeutics Building Exciting Pipeline Seekingalpha
Sep-21-17$155.36 (+1.28%)
11:36AMDaily Pharma Scoop Intercepts Buy Opportunity Alcobras Downfall Shires Japanese Approval Seekingalpha
Sep-18-17$155.66 (-1.77%)
10:06AMMylan Attacks Allergans Desperate Measures Protect Restasis Seekingalpha
09:25AMAldeyra Finally Gets Recognition Deserves Seekingalpha
Sep-14-17$157.83 (-1.17%)
08:39AMAldeyra Spikes Significant Improvements Midstage Dry Eye Study Seekingalpha
Sep-10-17
04:15AMAllergan Enjoins St Regis Mohawk Tribe Protect Restasis Patents Seekingalpha
Aug-31-17$149.39 (+2.48%)
12:33PMShire Stock Slump Offers Investment Opportunity With Strong Upcoming Catalysts Seekingalpha
Aug-27-17
03:33PM3 Things In Biotech You Should Learn Today: August 27, 2017 Seekingalpha
Aug-25-17$144.6 (+1.33%)
11:13AMRoche Is Almost At The Finish Line Seekingalpha
Aug-22-17$143.16 (+1.64%)
08:00AMShire: At 52-Week Low, Long-Term Opportunity Appears Significant Seekingalpha
Aug-18-17$145.55 (-1.62%)
03:32PMShire PLC 2017 Q2 - Results - Earnings Call Slides Seekingalpha
Aug-14-17$147.77 (-0.57%)
10:33AMCTI Biopharma's Pacritinib: Where We Stand Today Seekingalpha
Aug-10-17$149.97 (-2.53%)
10:07AMLooking Beyond Factors In Hemophilia Seekingalpha
Aug-05-17
03:37AMWhy Corporate Spinoffs For Shire And Valeant Make Sense Seekingalpha
Aug-04-17$155.91 (-3.51%)
04:10PMShire Q2/2017: Market Reaction Makes No Sense Seekingalpha
Aug-03-17$161.58 (-3.3%)
03:29PMNo Room For Neuroscience In New-Look Shire Seekingalpha
Aug-02-17$167.1 (-0.06%)
05:12PMCan NEOS Survive Efforts To Gain Market Share? Seekingalpha
09:41AMPharma Tightens Its Belt On Jobs As Markets Fall Seekingalpha
Jul-28-17$168.29 (-0.63%)
05:50PMKeep Your Eyes On Bioverativ In 2017 Seekingalpha
Jul-25-17$166.11 (+1.51%)
05:33PMDon't Lose The Faith In Shire Seekingalpha
04:10PMNektar Makes A Stride Forward In Resolving Autoimmune Diseases Seekingalpha
Jul-14-17$163.23 (-0.34%)
09:57AMNeos Therapeutics: All Angles Covered For PDUFA Seekingalpha
Jul-11-17$161.91 (-0.85%)
03:31PMGalafold Reversal Should Gladden Rare Disease Companies Seekingalpha
03:13PMAlnylam Buckles Down On A Belt Of Rare Diseases Seekingalpha
Jul-07-17$167.46 (+0.28%)
10:23AMBig Cap Biopharma Ends The Half Year On A High Note Seekingalpha
Jul-05-17$169.33 (+3.24%)
12:03PMA Look At Geron's Potential Myelofibrosis Competition Seekingalpha
Jun-29-17$165.3 (-3.79%)
07:19AMIs Sangamo Therapeutics Pointing Toward Success? Seekingalpha
Jun-27-17$171.91 (-0.85%)
03:16PMDova Pharmaceuticals: A Different Business Model Could Lead To Success Seekingalpha
12:35PMQ3 Biotech Catalyst Watch: Phase 2 Data Releases (Part 1) Seekingalpha
Jun-26-17$173.38 (+0.23%)
11:47AMRoche Brings New Blood To Hemophilia A Seekingalpha
Jun-23-17$172.98 (-1.11%)
11:11AMSnippet Roundup: CSL Makes HAE And Shire Extends ADHD Franchise Seekingalpha
Jun-21-17$170.75 (+2.09%)
07:38AMAmicus Therapeutics: Elucidating The Bullish And Bearish Claims Seekingalpha
May-16-17$184.79 (+1.58%)
09:14AMEWU Will Continue Its Rally Seekingalpha
May-04-17$180.25 (-0.77%)
11:39AMShire: Post-Earnings Analysis Seekingalpha
04:51AMIt's Time To Buy Shire Seekingalpha
May-02-17$184.11 (+4.33%)
09:25AMShire PLC 2017 Q1 - Results - Earnings Call Slides Seekingalpha
Apr-28-17$176.96 (-0.49%)
02:50PMHow Low Can You Go? U.S. Pharma Already Shoulders Light Tax Burden Seekingalpha
Apr-26-17$175.75 (-0.53%)
09:17AMFresenius Shows Biotech How To Get The Deals Done Seekingalpha
Apr-25-17$176.68 (+0.55%)
03:36PMInversion Reversion Puts Overseas Shopping Back In The Frame Seekingalpha
Apr-24-17$175.71 (+2.19%)
09:31AMNovo Nordisk's New Hemophilia-B Drug Will Have A Hard Time Getting Through FDA Panel Seekingalpha
Apr-15-17
11:31PMBiotech Core 5 For April Seekingalpha
Apr-11-17$169.64 (+0.58%)
03:05PMFirst-Quarter Deal Making Shows Glimmers Of Growth Seekingalpha
11:58AMShire: A Core Buy In Biotech With Deep Late-Stage Pipeline And Continued Growth Prospects Seekingalpha


Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GF Chat

{{numOfNotice}}
FEEDBACK